Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease.
J Immunol
; 206(7): 1454-1468, 2021 04 01.
Article
in En
| MEDLINE
| ID: mdl-33674445
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Basophils
/
Blood Platelets
/
Pemphigus
/
Purpura, Thrombocytopenic, Idiopathic
/
Protein Kinase Inhibitors
/
Agammaglobulinaemia Tyrosine Kinase
/
Kidney
/
Mast Cells
/
Anti-Inflammatory Agents
/
Nephritis
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Immunol
Year:
2021
Document type:
Article